A New One-a-Day-Pill Holds Promise for HIV's 'Forgotten Population'

New research published in The Lancet suggests a promising new once-daily HIV pill could simplify treatment for people with drug-resistant HIV who currently rely on complex, multi-pill regimens. The medication combines two existing drugs into a single tablet and performed as well as the more complicated treatments in a study of 550 patients.

Experts say simplifying lifelong HIV therapy could improve adherence, reduce side effects, and support viral suppression—an important public health goal because individuals with suppressed viral loads cannot transmit the virus.

If approved by the U.S. Food and Drug Administration, the drug could expand treatment options for a population often described by clinicians as overlooked in recent HIV treatment advances. Read the full article from NPR here.